The biotech company is preparing for the commercial launch of its flagship product, GenoPATHx, a pathogen testing kit that ...

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its ...

BioCatch, which prevents financial crime by recognizing patterns in human behavior, today announced the launch of the latest ...

BioCatch, which prevents financial crime by recognizing patterns in human behavior, posted its best second quarter in company ...

Douglas E. Williams, Ph.D. Strong track record at executive and board level of building company value across all stages of ...

Apple saw the strongest year-over-year growth during Q2 compared to its closest competitors, except in the U.S.

Korro Bio, Inc. (NASDAQ:KRRO – Free Report) – Investment analysts at William Blair lowered their Q2 2025 earnings per share (EPS) estimates for shares of Korro Bio in a research report issued ...

Apple has released its earnings report for fiscal Q2 2025. The company reports $95.4 billion in revenue during the three-month period. That ...

Snapchat parent Snap saw shares droop in after reporting first-quarter financials accompanied with a dose of realism. It's not offering Q2 guidance.

Climb Bio, Inc. (NASDAQ:CLYM – Free Report) – Equities researchers at Leerink Partnrs lifted their Q2 2025 earnings estimates for Climb Bio in a research note issued to investors on Tuesday ...

Bio-Techne Corporation (NASDAQ: TECH) Q2 2025 Earnings Conference Call February 5, 2025 9:00 AM ET Company Participants David Clair - Vice President-Investor Relations Kim Kelderman - President ...